ClinicalTrials.govpublic full text
To Evaluate the Blood Levels and Safety of IV and Subcutaneous CDP6038 in Subjects With Rheumatoid Arthritis Using Methotrexate
arthritis, rheumatoid arthritis, cdp6038, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 886507
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.